Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.29065 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.30866 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.28398 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.25741 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.99541 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.31706 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.63533 | 81 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.28246 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.32488 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.20249 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.34098 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.29535 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.47078 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.28753 | 77 |